JAK3 as an Emerging Target for Topical Treatment of Inflammatory Skin Diseases
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
JAK3 as an Emerging Target for Topical Treatment of Inflammatory Skin Diseases
Authors
Keywords
Psoriasis, Keratinocytes, Biopsy, Inflammatory diseases, Skin diseases, Atopic dermatitis, STAT signaling, Pyoderma
Journal
PLoS One
Volume 11, Issue 10, Pages e0164080
Publisher
Public Library of Science (PLoS)
Online
2016-10-07
DOI
10.1371/journal.pone.0164080
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway
- (2016) Ting-Ting Di et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
- (2015) John J. O'Shea et al. Annual Review of Medicine
- An Update on Topical Therapies for Mild-Moderate Psoriasis
- (2015) Peter C.M. van de Kerkhof DERMATOLOGIC CLINICS
- Treatment of recalcitrant atopic dermatitis with the oral Janus kinase inhibitor tofacitinib citrate
- (2015) Lauren L. Levy et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial
- (2015) Hervé Bachelez et al. LANCET
- An insight into JAK-STAT signalling in dermatology
- (2014) J. A. Palanivel et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Mechanisms of Jak/STAT Signaling in Immunity and Disease
- (2014) Alejandro V. Villarino et al. JOURNAL OF IMMUNOLOGY
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
- (2014) Brittany G. Craiglow et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- (2014) Luzhou Xing et al. NATURE MEDICINE
- Identifying targets for topical RNAi therapeutics in psoriasis: assessment of a new in vitro psoriasis model
- (2013) S. Bracke et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Oral lichen planus: Focus on etiopathogenesis
- (2013) Márcia Rodrigues Payeras et al. ARCHIVES OF ORAL BIOLOGY
- A randomized phase 2a efficacy and safety trial of the topical Janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis
- (2013) W.C. Ports et al. BRITISH JOURNAL OF DERMATOLOGY
- Jakpot! New small molecules in autoimmune and inflammatory diseases
- (2013) Kamran Ghoreschi et al. EXPERIMENTAL DERMATOLOGY
- Studies of Jak/STAT3 expression and signalling in psoriasis identifies STAT3-Ser727 phosphorylation as a modulator of transcriptional activity
- (2013) Rosa M. Andrés et al. EXPERIMENTAL DERMATOLOGY
- Tyk2 is a therapeutic target for psoriasis-like skin inflammation
- (2013) M. Ishizaki et al. INTERNATIONAL IMMUNOLOGY
- Effects of the Janus Kinase Inhibitor CP-690550 (Tofacitinib) in a Rat Model of Oxazolone-Induced Chronic Dermatitis
- (2013) Yasutomo Fujii et al. PHARMACOLOGY
- IL-6, IL-17 and STAT3: a holy trinity in auto-immunity?
- (2012) Annalisa Camporeale Frontiers in Bioscience-Landmark
- Preliminary clinical activity of a topical JAK1/2 inhibitor in the treatment of psoriasis
- (2012) Naresh Punwani et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- IL-4 regulates chemokine CCL26 in keratinocytes through the Jak1, 2/Stat6 signal transduction pathway: Implication for atopic dermatitis
- (2012) Lei Bao et al. MOLECULAR IMMUNOLOGY
- JAKs go nuclear: Emerging role of nuclear JAK1 and JAK2 in gene expression and cell growth
- (2011) Fouad A. Zouein et al. GROWTH FACTORS
- Contrasting pathogenesis of atopic dermatitis and psoriasis—Part II: Immune cell subsets and therapeutic concepts
- (2011) Emma Guttman-Yassky et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Contrasting pathogenesis of atopic dermatitis and psoriasis—Part I: Clinical and pathologic concepts
- (2011) Emma Guttman-Yassky et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- IL-17A Upregulates Keratin 17 Expression in Keratinocytes through STAT1- and STAT3-Dependent Mechanisms
- (2011) Xiaowei Shi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- An Autoimmune Phenotype in Vulvar Lichen Sclerosus and Lichen Planus: A Th1 Response and High Levels of MicroRNA-155
- (2011) Annelinde Terlou et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Signal transduction by the atopy-associated human thymic stromal lymphopoietin (TSLP) receptor depends on Janus kinase function
- (2010) Andreas Wohlmann et al. BIOLOGICAL CHEMISTRY
- STAT2 Contributes to Promotion of Colorectal and Skin Carcinogenesis
- (2010) A. M. Gamero et al. Cancer Prevention Research
- Stat3 as a Therapeutic Target for the Treatment of Psoriasis: A Clinical Feasibility Study with STA-21, a Stat3 Inhibitor
- (2010) Ken Miyoshi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- JAK3 Inhibition Significantly Attenuates Psoriasiform Skin Inflammation in CD18 Mutant PL/J Mice
- (2009) B. Y. Chang et al. JOURNAL OF IMMUNOLOGY
- Cytokine Signaling Modules in Inflammatory Responses
- (2008) John J. O'Shea et al. IMMUNITY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started